Total Payments
$42,982
2024 Payments
$15.90
Companies
19
Transactions
231
Medicare Patients
9,177
Medicare Billing
$804,217
Payment Breakdown by Category
Other$37,936 (88.3%)
Food & Beverage$3,628 (8.4%)
Travel$1,218 (2.8%)
Education$200.03 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,936 | 23 | 88.3% |
| Food and Beverage | $3,628 | 194 | 8.4% |
| Travel and Lodging | $1,218 | 8 | 2.8% |
| Education | $200.03 | 6 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $40,874 | 105 | $0 (2021) |
| PFIZER INC. | $390.36 | 27 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $360.98 | 15 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $305.29 | 15 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $244.08 | 22 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $148.67 | 10 | $0 (2021) |
| Medtronic USA, Inc. | $99.27 | 1 | $0 (2018) |
| Amarin Pharma Inc. | $93.35 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $87.50 | 6 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $79.24 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.90 | 1 | ZOLL Medical Corporation ($15.90) |
| 2023 | $16.33 | 1 | PFIZER INC. ($16.33) |
| 2021 | $7,458 | 43 | Amgen Inc. ($6,969) |
| 2020 | $4,633 | 34 | Amgen Inc. ($4,370) |
| 2019 | $5,824 | 56 | Amgen Inc. ($5,238) |
| 2018 | $11,137 | 48 | Amgen Inc. ($10,668) |
| 2017 | $13,897 | 48 | Amgen Inc. ($13,629) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | ZOLL Medical Corporation | Defibrillator (Device) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Resuscitation | ||||||
| 10/27/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/01/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.65 | General |
| 06/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.02 | General |
| Category: Cardiovascular | ||||||
| 06/11/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/10/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/03/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/02/2021 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 06/02/2021 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 06/02/2021 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $145.60 | General |
| Category: Cardiology | ||||||
| 05/27/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.25 | General |
| 05/26/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $84.89 | General |
| Category: Cardiology | ||||||
| 05/25/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/24/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/18/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Cardiology | ||||||
| 05/13/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Cardiovascular | ||||||
| 05/07/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2021 | Abbott Laboratories | MitraClip System (Device) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Structural Heart | ||||||
| 05/03/2021 | Abbott Laboratories | MitraClip System (Device) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Structural Heart | ||||||
| 04/29/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,201 | 3,570 | $1.4M | $195,752 |
| 2022 | 26 | 2,167 | 3,029 | $1.2M | $176,536 |
| 2021 | 34 | 2,343 | 3,606 | $786,405 | $227,758 |
| 2020 | 36 | 2,466 | 3,851 | $786,227 | $204,171 |
Total Patients
9,177
Total Services
14,056
Medicare Billing
$804,217
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 909 | $235,431 | $79,414 | 33.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 118 | 119 | $141,745 | $22,717 | 16.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 245 | $56,350 | $14,922 | 26.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 59 | 120 | $43,560 | $10,616 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 92 | 103 | $302,470 | $10,511 | 3.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 44 | 180 | $43,740 | $8,283 | 18.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 381 | 629 | $93,092 | $6,365 | 6.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 43 | $16,727 | $5,451 | 32.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $84,151 | $4,108 | 4.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 44 | $18,700 | $4,100 | 21.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 75 | 76 | $90,440 | $3,983 | 4.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $11,584 | $3,685 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 54 | $9,666 | $3,089 | 32.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 28 | 29 | $46,071 | $2,862 | 6.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 45 | 46 | $38,962 | $2,168 | 5.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 22 | $7,700 | $2,028 | 26.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 241 | 302 | $22,650 | $1,903 | 8.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 33 | 101 | $13,635 | $1,649 | 12.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 23 | 68 | $10,744 | $1,545 | 14.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 28 | 36 | $7,686 | $1,253 | 16.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 77 | 77 | $15,785 | $1,246 | 7.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 77 | 77 | $18,634 | $823.08 | 4.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,465 | $704.66 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 82 | $1,886 | $688.80 | 36.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 16 | 21 | $2,205 | $399.32 | 18.1% |
About Dr. Himadri Dasgupta, MD
Dr. Himadri Dasgupta, MD is a Cardiovascular Disease healthcare provider based in Lexington, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265489512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Himadri Dasgupta, MD has received a total of $42,982 in payments from pharmaceutical and medical device companies, with $15.90 received in 2024. These payments were reported across 231 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,936).
As a Medicare-enrolled provider, Dasgupta has provided services to 9,177 Medicare beneficiaries, totaling 14,056 services with total Medicare billing of $804,217. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lexington, SC
- Active Since 05/30/2006
- Last Updated 08/25/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1265489512
Products in Payments
- Repatha (Biological) $37,908
- Corlanor (Drug) $2,956
- ELIQUIS (Drug) $618.11
- BRILINTA (Drug) $308.25
- XARELTO (Drug) $305.29
- ENTRESTO (Drug) $148.67
- Solitaire (Device) $99.27
- Vascepa (Drug) $93.35
- VERQUVO (Drug) $87.50
- LifeVest (Device) $79.24
- MitraClip System (Device) $51.62
- MULTAQ (Drug) $50.72
- ZONTIVITY (Drug) $40.54
- NEXLETOL (Drug) $38.35
- ZIO Patch (Device) $18.61
- Edarbi (Drug) $17.98
- Edarbyclor (Drug) $17.98
- Cardiac Monitoring Suite (Device) $17.01
- VYNDAQEL (Drug) $16.33
- PRALUENT (Biological) $16.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lexington
Dr. William Skinner, Md, MD
Cardiovascular Disease — Payments: $463,034
Cardiovascular Disease $463,034
Dr. Steve Lin, Md, MD
Cardiovascular Disease — Payments: $310,565
Cardiovascular Disease $310,565
Dr. Joseph Souza, M.d, M.D
Cardiovascular Disease — Payments: $238,102
Cardiovascular Disease $238,102
Gery Tomassoni, M.d, M.D
Cardiovascular Disease — Payments: $215,300
Cardiovascular Disease $215,300
Armaghan Soomro, Md, MD
Cardiovascular Disease — Payments: $114,497
Cardiovascular Disease $114,497
Dr. Adrian Messerli, Md, MD
Cardiovascular Disease — Payments: $67,777
Cardiovascular Disease $67,777